Searchable abstracts of presentations at key conferences on calcified tissues

ba0005cabs.op1.2 | Oral Poster Talks | ECTS2016

Roundabout receptors: new actors in bone metastatic niche formation

Clement-Demange Lise , Le Pape Francois , Eckel Benedicte , Geraci Sandra , Diaz-Latoud Chantal , Clezardin Philippe

Roundabout receptors are crucial regulators of vessels and axons growth during development. A comparative transcriptomic study between the MDA-MB-231 breast cancer cell line and its osteotropic subpopulation, MDA-B02 cells, has shown an overexpression of ROBO4 receptor. Interestingly, a high ROBO4 expression in primary tumour from patients with breast cancer correlates with poor prognosis and increased risk of bone metastasis relapse. Inoculation of ROBO4 depleted cells in the...

ba0003pp156 | Cell biology: osteoclasts and bone resorption | ECTS2014

Interleukin-34 and macrophage-colony stimulating factor interact to form a heteromeric and functional cytokine

Segaliny Aude , Brion Regis , Brulin Benedicte , Teletchea Stephane , Jardin Julien , Maillasson Mike , Charrier Celine , Heymann Dominique

Interleukin-34 (IL-34) is a newly discovered cytokine which regulates, like macrophage-colony stimulating factor (M-CSF), the differentiation/activation of the myeloid lineage. IL-34 and M-CSF are homodimers known to bind to the M-CSF receptor (M-CSFR) in a competitive manner. In this system, IL-34 can substitute for the M-CSF to induce osteoclastic differentiation. The aim of the present work was to study the functional relationships of these cytokines on cells expressing the...

ba0003pp318 | Osteoporosis: treatment | ECTS2014

Preferences of patients and health care professionals for osteoporosis drug treatment: a discrete choice experiment

Hiligsmann Mickael , Dirksen Carmen , Dellaert Benedict , van der Weijden Trudy , Goemaere Stefan , Reginster Jean-Yves , Watson Verity , Boonen Annelies

Objectives: This study aims to evaluate and compare the preferences of patients and health care professionals for osteoporotic drug treatment.Materials and methods: A discrete choice experiment was conducted among patients and health care professionals (general physicians, rheumatologists, and geriatricians) in Belgium. Participants were asked to choose between two hypothetical unlabelled drug treatments (and an opt-out option) that vary in several attri...